Citations

Clear

3138 citation(s) found for "Smith, AM".

Prospective Consecutive Clinical Outcomes After Transtibial Root Repair for Posterior Meniscal Root Tears: A Multicenter Study
Krych, Aaron J. , Song, Bryant M. , Nauert, Richard F. , Cook, Corey S., Levy, Bruce A. , Smith, Patrick A. , Krych, Aaron J , Camp, Christopher L. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | February 24, 2022 | Volume: 10 | Issue: 2 | Pages: No page available

10.1177/23259671221079794 | PMID 35237699 Get It

Background: Prospective evaluation of clinical outcomes after posterior meniscal root repair utilizing a transtibial pullout technique is limited, and factors that may contribute to outcomes are unclear. Hypothesis: It was hypothesized that there would be an overall significant improvement in outcomes after root repair and that differences in clinical outcomes would correlate with age, body mass index (BMI), sex, and meniscal extrusion. Study Design: Case-control study; Level of evidence, 3. Methods: Consecutive patients undergoing transtibial medial or lateral meniscal root repair were enrolled prospectively at 2 orthopaedic centers between March 2017 and January 2019. Pre- and postoperative magnetic resonance imaging (MRI) were obtained to assess for meniscal healing, quantification of extrusion, articular cartilage grade, and subchondral bone changes. Patient-reported outcomes including International Knee Documentation Committee (IKDC) scores, Tegner activity scale, and visual analog scale (VAS) for pain were collected preoperatively and 2 years postoperatively. Patients were then subdivided by clinical and demographic characteristics to determine factors associated with clinical outcomes. Results: Included were 45 patients (29 female, 16 male; mean age, 42.3 ± 12.9 years; mean BMI, 31.6 kg/m 2 ) who underwent 47 meniscal root repairs (29 medial and 16 lateral; 2 had both). Significant improvements at 2-year follow-up were seen in IKDC score (41.1 vs 78.4; P < .001), Tegner activity level (3 vs 4; P < .001), and VAS pain (2.8 vs 0.7; P < .001). BMI, preoperative malalignment, cartilage status, and progressive meniscus extrusion (Δ = 0.7 mm) did not have a negative impact on IKDC and Tegner scores 2 years postoperatively. Age greater than or equal to 50 years and extrusion pre- and postoperatively were associated with decreased Tegner scores. Progressive meniscal extrusion was associated with a decreased overall improvement in Tegner scores. Conclusion: Transtibial root repair for medial and lateral posterior meniscal root tears demonstrated significantly improved clinical outcomes at 2 years postoperatively. Increased age, increased BMI, cartilage status, and meniscal extrusion did not have a negative impact on short-term functional outcomes (IKDC), but age greater than or equal to 50 years and extrusion negatively influenced patient activity level (Tegner). Registration: NCT03037242 ( ClinicalTrials.gov identifier).
Social Isolation and Incident Heart Failure Hospitalization in Older Women: Women’s Health Initiative Study Findings
Cené, Crystal W. , Leng, Xiaoyan , Faraz, Khushnood , Allison, Matthew , Breathett, Khadijah , Bird, Chloe E. , Coday, Mace , Corbie‐Smith, Giselle , Foraker, Randi E. , Ijioma, Nkechinyere , Rosal, Milagros C. , Sealy–Jefferson, Shawnita , Shippee, Tetyana , Rossouw, Jacques E. , Ludlam, Shari, McGowan, Joan, Ford, Leslie, Geller, Nancy L. , Prentice, Ross, LaCroix, Andrea Z. , Kooperberg, Charles, Howard, Barbara V. , Jackson, Rebecca D. , Thomson, Cynthia A. , Limacher, Marian C. , Robinson, Jennifer G., Kuller, Lewis, Shumaker, Sally A., Brunner, Robert L. , Bird, Chloe , Foraker, Randi , Ijioma, Nkechinyere N, Kroenke, Candyce H , Ijioma, Nkechi , Breathett, Khadijah , Allison, Matthew A , Anderson, Garnet L. , Manson, JoAnn E. , Stefanick, Marcia L , Wactawski‐Wende, Jean

Mayo Clinic

Journal of the American Heart Association | February 22, 2022 | Volume: 11 | Issue: 5 | Pages: No page available

10.1161/jaha.120.022907 | PMID 35189692 Get It

Background The association of social isolation or lack of social network ties in older adults is unknown. This knowledge gap is important since the risk of heart failure (HF) and social isolation increase with age. The study examines whether social isolation is associated with incident HF in older women, and examines depressive symptoms as a potential mediator and age and race and ethnicity as effect modifiers. Methods and Results This study included 44 174 postmenopausal women of diverse race and ethnicity from the WHI (Women's Health Initiative) study who underwent annual assessment for HF adjudication from baseline enrollment (1993–1998) through 2018. We conducted a mediation analysis to examine depressive symptoms as a potential mediator and further examined effect modification by age and race and ethnicity. Incident HF requiring hospitalization was the main outcome. Social isolation was a composite variable based on marital/partner status, religious ties, and community ties. Depressive symptoms were assessed using CES‐D (Center for Epidemiology Studies‐Depression). Over a median follow‐up of 15.0 years, we analyzed data from 36 457 women, and 2364 (6.5%) incident HF cases occurred; 2510 (6.9%) participants were socially isolated. In multivariable analyses adjusted for sociodemographic, behavioral, clinical, and general health/functioning; socially isolated women had a higher risk of incident HF than nonisolated women (HR, 1.23; 95% CI, 1.08–1.41). Adding depressive symptoms in the model did not change this association (HR, 1.22; 95% CI, 1.07–1.40). Neither race and ethnicity nor age moderated the association between social isolation and incident HF. Conclusions Socially isolated older women are at increased risk for developing HF, independent of traditional HF risk factors. Registration URL: http://www.clinicaltrials.gov ; Unique identifier: NCT00000611.
Association of hypothyroidism with outcomes in hospitalized adults with COVID‐19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID‐19 Registry
Bogojevic, Marija , Bansal, Vikas , Pattan, Vishwanath , Tekin, Aysun , Sharma, Mayank , Nou, Abigail T. La, Hanson, Andrew C. , Schulte, Phillip J. , Qamar, Shahraz , Morales, Diana J. Valencia , Perkins, Nicholas , Kaufman, Margit, Melamed, Roman , Christie, Amy B. , Tarabichi, Yasir , Heavner, Smith F. , Kumar, Vishakha K. , Bhagra, Sumit , Lal, Amos , Domecq, Juan Pablo , Group, Society of Critical Care Medicine (SCCM) Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID‐19 Registry Investigator, Koritala, Thoyaja , Asghar, Muhammad Sohaib , Singh, Romil , La Nou, Abigail T, Zec, Simon , Valencia Morales, Diana J , Denson, Joshua L , Gajic, Ognjen , Kashyap, Rahul , Lal, Amos , Domecq, Juan Pablo , Bansal, Vikas , Asghar, Muhammad S , Tekin, Aysun , Domecq Graces, Juan Pablo , Nou, Abigail La, LeMahieu, Allison , Deo, Neha , Denson, Joshua L. , Banner‐Goodspeed, Valerie , Walkey, Allan J. , Gajic, Ognjen , Kashyap, Rahul , Group, Society of Critical Care Medicine (SCCM) Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID‐19 Registry Investigator

Mayo Clinic

Clinical Endocrinology | February 18, 2022 | Volume: 101 | Issue: 1 | Pages: 85-93

10.1111/cen.14699 | PMID 35180316 Get It

AbstractIntroductionCoronavirus disease 2019 (COVID‐19) is associated with high rates of morbidity and mortality. Primary hypothyroidism is a common comorbid condition, but little is known about its association with COVID‐19 severity and outcomes. This study aims to identify the frequency of hypothyroidism in hospitalized patients with COVID‐19 as well as describe the differences in outcomes between patients with and without pre‐existing hypothyroidism using an observational, multinational registry.MethodsIn an observational cohort study we enrolled patients 18 years or older, with laboratory‐confirmed severe acute respiratory syndrome coronavirus‐2 infection between March 2020 and February 2021. The primary outcomes were (1) the disease severity defined as per the World Health Organization Scale for Clinical Improvement, which is an ordinal outcome corresponding with the highest severity level recorded during a patient's index COVID‐19 hospitalization, (2) in‐hospital mortality and (3) hospital‐free days. Secondary outcomes were the rate of intensive care unit (ICU) admission and ICU mortality.ResultsAmong the 20,366 adult patients included in the study, pre‐existing hypothyroidism was identified in 1616 (7.9%). The median age for the Hypothyroidism group was 70 (interquartile range: 59–80) years, and 65% were female and 67% were White. The most common comorbidities were hypertension (68%), diabetes (42%), dyslipidemia (37%) and obesity (28%). After adjusting for age, body mass index, sex, admission date in the quarter year since March 2020, race, smoking history and other comorbid conditions (coronary artery disease, hypertension, diabetes and dyslipidemia), pre‐existing hypothyroidism was not associated with higher odds of severe disease using the World Health Organization disease severity index (odds ratio [OR]: 1.02; 95% confidence interval [CI]: 0.92, 1.13; p = .69), in‐hospital mortality (OR: 1.03; 95% CI: 0.92, 1.15; p = .58) or differences in hospital‐free days (estimated difference 0.01 days; 95% CI: −0.45, 0.47; p = .97). Pre‐existing hypothyroidism was not associated with ICU admission or ICU mortality in unadjusted as well as in adjusted analysis.ConclusionsIn an international registry, hypothyroidism was identified in around 1 of every 12 adult hospitalized patients with COVID‐19. Pre‐existing hypothyroidism in hospitalized patients with COVID‐19 was not associated with higher disease severity or increased risk of mortality or ICU admissions. However, more research on the possible effects of COVID‐19 on the thyroid gland and its function is needed in the future.
AAPM task group report 302: Surface‐guided radiotherapy
Al‐Hallaq, Hania , Gutiérrez, Alonso N. , Havnen‐Smith, Amanda, Higgins, Susan A., Kügele, M. , Padilla, Laura , Pawlicki, Todd , Remmes, Nicholas B. , Smith, Koren, Tomé, Wolfgang A. , Havnen-Smith, Amanda, Remmes, Nicholas, Cerviño, Laura , Tang, Xiaoli

Mayo Clinic

Medical Physics | February 18, 2022 | Volume: 49 | Issue: 4 | Pages: No page available

10.1002/mp.15532 | PMID 35179229 Get It

Abstract The clinical use of surface imaging has increased dramatically, with demonstrated utility for initial patient positioning, real‐time motion monitoring, and beam gating in a variety of anatomical sites. The Therapy Physics Subcommittee and the Imaging for Treatment Verification Working Group of the American Association of Physicists in Medicine commissioned Task Group 302 to review the current clinical uses of surface imaging and emerging clinical applications. The specific charge of this task group was to provide technical guidelines for clinical indications of use for general positioning, breast deep‐inspiration breath hold treatment, and frameless stereotactic radiosurgery. Additionally, the task group was charged with providing commissioning and on‐going quality assurance (QA) requirements for surface‐guided radiation therapy (SGRT) as part of a comprehensive QA program including risk assessment. Workflow considerations for other anatomic sites and for computed tomography simulation, including motion management, are also discussed. Finally, developing clinical applications, such as stereotactic body radiotherapy (SBRT) or proton radiotherapy, are presented. The recommendations made in this report, which are summarized at the end of the report, are applicable to all video‐based SGRT systems available at the time of writing.
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women
O’Kelly, Anna C. , Michos, Erin D. , Vermunt, Jane , Minissian, Margo , Smith, Graeme N. , Rich‐Edwards, Janet W. , Khoudary, Samar R. El , Vermunt, Jane V, Smith, Graeme N , Rich-Edwards, Janet W , Garovic, Vesna D , El Khoudary, Samar R , Honigberg, Michael C , Michos, Erin D , Shufelt, Chrisandra , Quesada, Odayme , Garovic, Vesna D. , Honigberg, Michael C.

Mayo Clinic

Circulation Research | February 17, 2022 | Volume: 130 | Issue: 4 | Pages: 652-672

10.1161/circresaha.121.319895 | PMID 35175837 Get It

Beyond conventional risk factors for cardiovascular disease, women face an additional burden of sex-specific risk factors. Key stages of a woman’s reproductive history may influence or reveal short- and long-term cardiometabolic and cardiovascular trajectories. Early and late menarche, polycystic ovary syndrome, infertility, adverse pregnancy outcomes (eg, hypertensive disorders of pregnancy, gestational diabetes, preterm delivery, and intrauterine growth restriction), and absence of breastfeeding are all associated with increased future cardiovascular disease risk. The menopause transition additionally represents a period of accelerated cardiovascular disease risk, with timing (eg, premature menopause), mechanism, and symptoms of menopause, as well as treatment of menopause symptoms, each contributing to this risk. Differences in conventional cardiovascular disease risk factors appear to explain some, but not all, of the observed associations between reproductive history and later-life cardiovascular disease; further research is needed to elucidate hormonal effects and unique sex-specific disease mechanisms. A history of reproductive risk factors represents an opportunity for comprehensive risk factor screening, refinement of cardiovascular disease risk assessment, and implementation of primordial and primary prevention to optimize long-term cardiometabolic health in women.
Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools
Adedinsewo, Demilade , Pollak, Amy W., Phillips, Sabrina D., Smith, Taryn L., Svatikova, Anna, Hayes, Sharonne N. , Mulvagh, Sharon L., Norris, Colleen M. , Roger, Véronique L. , Noseworthy, Peter A. , Carter, Rickey E. , Adedinsewo, Demilade A , Norris, Colleen , Yao, Xiaoxi , Carter, Rickey E , Noseworthy, Peter A , Hayes, Sharonne N , Pollak, Amy W., Phillips, Sabrina D., Smith, Taryn L., Svatikova, Anna, Mulvagh, Sharon L., Roger, Veronique L

Mayo Clinic

Circulation Research | February 17, 2022 | Volume: 130 | Issue: 4 | Pages: 673-690

10.1161/circresaha.121.319876 | PMID 35175849 Get It

Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman’s life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.
A counseling strategy was better than usual care for adopting and maintaining physical activity in type 2 diabetes
Smith, Steven A., Vickers, Kristin S.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 139 | Issue: 3 | Pages: 69

10.7326/acpjc-2003-139-3-069 | PMID 14594420 Get It

Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus
Gami, Apoor S., Smith, Steven A.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 142 | Issue: 2 | Pages: 29

10.7326/acpjc-2005-142-2-029 | PMID 15739976 Get It

Sex Differences in Cardiac Rehabilitation Outcomes
Smith, Joshua R. , Thomas, Randal J., Bonikowske, Amanda R., Hammer, Shane M., Olson, Thomas P., Hammer, Shane M. , Smith, Joshua R , Thomas, Randal J., Bonikowske, Amanda R., Olson, Thomas P.

Mayo Clinic

Circulation Research | February 17, 2022 | Volume: 130 | Issue: 4 | Pages: 552-565

10.1161/circresaha.121.319894 | PMID 35175838 Get It

Cardiovascular disease is a leading cause of morbidity and mortality in males and females in the United States and globally. Cardiac rehabilitation (CR) is recommended by the American Heart Association/American College of Cardiology for secondary prevention for patients with cardiovascular disease. CR participation is associated with improved cardiovascular disease risk factor management, quality of life, and exercise capacity as well as reductions in hospital admissions and mortality. Despite these advantageous clinical outcomes, significant sex disparities exist in outpatient phase II CR programming. This article reviews sex differences that are present in the spectrum of care provided by outpatient phase II CR programming (ie, from referral to clinical management). We first review CR participation by detailing the sex disparities in the rates of CR referral, enrollment, and completion. In doing so, we discuss patient, health care provider, and social/environmental level barriers to CR participation with a particular emphasis on those barriers that majorly impact females. We also evaluate sex differences in the core components incorporated into CR programming (eg, patient assessment, exercise training, hypertension management). Next, we review strategies to mitigate these sex differences in CR participation with a focus on automatic CR referral, female-only CR programming, and hybrid CR. Finally, we outline knowledge gaps and areas of future research to minimize and prevent sex differences in CR programming.
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence
Venkatramani, Vivek , Gonzalgo, Mark L. , Castle, Erik P., Svatek, Robert S. , Weizer, Alon Z. , Konety, Badrinath R. , Tollefson, Mathew, Krupski, Tracey L. , Smith, Norm D. , Shabsigh, Ahmad , Barocas, Daniel A. , Dash, Atreya , Parekh, Dipen J. , Reis, Isildinha Marques dos , Woods, Michael E. , Quek, Marcus Lee

Mayo Clinic

JAMA Network Open | February 16, 2022 | Volume: 5 | Issue: 2 | Pages: e2148329

10.1001/jamanetworkopen.2021.48329 | PMID 35171260 Get It